Real IPM

PUBLIC

Name	Real IPM
Tagline	Provides biological control and integrated pest management solutions for horticulture and floriculture in East Africa.
Headquarters	Thika, Kenya
Founded	2003
Stage	Exited
Business Model	B2B
Industry	Agtech
Technology	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Links

PUBLIC

• Website: https://realipm.com/
• LinkedIn: https://ke.linkedin.com/company/real-ipm

Executive Summary

PUBLIC Real IPM built a durable, asset-heavy business by addressing a specific regulatory and commercial pressure point for East Africa's horticulture exporters. Founded in 2003, the company became a leading regional supplier of biological pest control and bio-fertilizers, a position validated by its acquisition by the global biocontrol leader Biobest in 2016 [PitchBook]. The core proposition is straightforward: provide growers, particularly in floriculture, with a suite of registered biopesticides and predatory mites to replace synthetic chemicals, enabling compliance with strict international residue standards for export [Perplexity Sonar Pro Brief].

Founders Louise Labuschagne and Dr. Henry Wainwright established the company in Thika, Kenya, a strategic location within the country's agricultural heartland, and grew it to employ over 300 staff [Devex]. The business model combines product sales of manufactured biological agents with recurring service revenue from training, consultancy, and scouting, creating multiple touchpoints with commercial farms. While the specific amounts are undisclosed, the company secured early backing from impact-focused investors Africa Enterprise Challenge Fund and Pearl Capital Partners, signaling institutional confidence in its model [PitchBook].

For an investor evaluating the legacy of this venture, the key watchpoints are the integration success within the Biobest Group and the potential for the Real IPM brand and regional registration portfolio to serve as a platform for further expansion across the continent.

Data Accuracy: GREEN -- Core facts (founding, acquisition, product focus, team) are corroborated by multiple independent directories and the acquirer's own materials.

Taxonomy Snapshot

Axis	Classification
Stage	Exited
Business Model	B2B
Industry / Vertical	Agtech
Technology Type	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Company Overview

PUBLIC

Real IPM began as a biological control specialist in 2003, founded by Louise Labuschagne and Dr. Henry Wainwright in Thika, Kenya [Devex]. The company was established to address a specific market need: providing commercial horticulture and floriculture exporters, particularly rose growers, with alternatives to synthetic pesticides to meet stringent international residue standards [Perplexity Sonar Pro Brief]. Its early focus on predatory mites and biopesticides positioned it as a local producer of integrated pest management (IPM) solutions for East Africa's export-oriented agricultural sector.

A significant corporate milestone occurred in December 2016 when the company was acquired by BioFirst Group, which operates as part of the global Biobest Group [PitchBook, Crunchbase]. Post-acquisition, Real IPM continued to operate as a member of the Biobest Group, with Dr. Wainwright remaining as general manager in Kenya for a transition period [Real IPM]. The acquisition integrated its regional production and distribution capabilities into a larger biological control network. The company has since expanded its physical footprint, with a noted presence in Uganda through a separate operational entity [Perplexity Sonar Pro Brief].

Headcount figures from public sources indicate the organization scaled to a substantial size for an agtech operation in the region. One source reports over 300 staff members [Real IPM], while another cites 228 employees [Devex]. This workforce supports its manufacturing, research, and field service operations across multiple countries.

Data Accuracy: YELLOW -- Core facts (founding, acquisition, founders) are consistently reported across multiple directories. Headcount and specific operational details are sourced from company materials or single third-party profiles.

Product and Technology

MIXED The company's product suite is defined by a biological, rather than chemical, approach to crop protection and fertility. Real IPM's core offerings are live predatory mites and formulated biopesticides, which are deployed as alternatives to synthetic pesticides for commercial growers, particularly in export-oriented floriculture and horticulture [Real IPM].

The flagship biological control agent is Real Phytoseiulus, a product containing the predatory mite Phytoseiulus persimilis used to manage the two-spotted spider mite (Tetranychus urticae), a major pest for rose growers [Crunchbase]. Beyond predators, the company produces a range of registered biopesticides derived from beneficial fungi and bacteria, which are mass-produced as crop protection agents [Real IPM]. These biopesticides hold regulatory registration in at least seven African countries: Kenya, Tanzania, Uganda, Ethiopia, Ghana, Mozambique, and South Africa [Real IPM].

A later addition to the portfolio is the bio-fertilizer Mazao Flourish, described as a mixture of two beneficial microorganisms designed to promote plant growth, increase yield, and reduce biotic stress for a range of crops [Perplexity Sonar Pro Brief]. The commercial model extends beyond product sales to include integrated services such as training, contract research, consultancy, and field scouting for growers, positioning the company as a full-service IPM partner [Perplexity Sonar Pro Brief].

Data Accuracy: GREEN -- Product details and registration status are confirmed by the company's own website and materials, with secondary corroboration from industry sources.

Market Research

PUBLIC The demand for residue-free produce, driven by stringent export standards and consumer preference, is creating a durable market for biological pest control in commercial agriculture.

The core market for Real IPM is East African horticulture and floriculture, specifically exporters of flowers and fresh produce who must meet strict pesticide residue limits for European and other international markets [Perplexity Sonar Pro Brief]. The company's primary customer focus is on these commercial growers, with an additional segment of smallholder farmers [Perplexity Sonar Pro Brief]. While a specific TAM for biological controls in East Africa is not publicly available, the broader global biopesticides market provides an analogous reference. According to a 2022 report from MarketsandMarkets, the global biopesticides market was valued at $6.7 billion and was projected to reach $13.9 billion by 2027, growing at a compound annual growth rate of 15.7% [MarketsandMarkets, 2022]. This growth significantly outpaces that of the conventional chemical pesticide market.

Key demand drivers for Real IPM's solutions are well-documented. The primary tailwind is regulatory pressure from export markets, where maximum residue levels for synthetic chemicals continue to tighten. This creates a direct economic incentive for growers to adopt integrated pest management (IPM) strategies that reduce chemical dependency. A secondary driver is the rising cost and decreasing efficacy of some synthetic pesticides due to pest resistance, alongside growing consumer and retailer demand for sustainably produced goods. The company's product registration across seven African countries,Kenya, Tanzania, Uganda, Ethiopia, Ghana, Mozambique, and South Africa [Real IPM],signals both the geographic scope of the regulatory opportunity and the company's proactive efforts to secure market access.

Adjacent and substitute markets influence the competitive dynamic. The primary substitute remains the conventional synthetic pesticide market, which is larger and more established but faces the aforementioned headwinds. Adjacent markets include the broader biologicals sector, encompassing bio-stimulants and bio-fertilizers like Real IPM's own Mazao Flourish product [Perplexity Sonar Pro Brief]. This product expansion indicates the company is targeting the complementary need for plant nutrition and stress reduction, moving beyond pure pest control into holistic crop health.

Regulatory and macro forces are pivotal. Beyond export regulations, national pesticide registration regimes in each African country constitute a significant barrier to entry and a moat for incumbents with approved products. Macro forces include climate change, which can alter pest pressures and increase the appeal of resilient, biological systems, and foreign direct investment in African agribusiness, which could increase the scale of commercial farming operations that are natural customers for Real IPM's offerings.

Global Biopesticides Market 2022 | 6.7 | $B
Projected Market 2027 | 13.9 | $B

The projected near-doubling of the global biopesticides market over a five-year period underscores the sector's momentum, though Real IPM's actual serviceable market is a fraction of this global figure, concentrated in specific export-oriented crop segments in East Africa.

Data Accuracy: YELLOW -- Market sizing is drawn from an analogous global report; specific regional TAM and SAM are not publicly quantified. Demand drivers and regulatory scope are corroborated by multiple source descriptions.

Competitive Landscape

MIXED Real IPM's competitive position is defined by its regional focus on East African export horticulture and its integrated model of biological product manufacturing and on-farm advisory services.

The competitive analysis proceeds as prose.

The competitive map for biological pest control in East Africa is segmented by the type of provider. The primary incumbents are large, global biocontrol corporations like Biobest Group, which now owns Real IPM, and Koppert Biological Systems. These players have extensive R&D resources and global distribution networks but may not have the same depth of on-the-ground, crop-specific expertise for local East African pests and growing conditions. The challengers are smaller, often local, producers of biopesticides or beneficial insects, which may compete on price for a single product but lack the full-service integrated pest management (IPM) offering. Adjacent substitutes include traditional chemical pesticide suppliers and generic fertilizer companies, which compete on familiarity and immediate efficacy but face growing regulatory and market pressure regarding chemical residues on export crops [Real IPM].

Real IPM's defensible edge today rests on two pillars: its locally adapted product portfolio and its embedded service model. The company's biopesticides are specifically registered for use in Kenya, Tanzania, Uganda, Ethiopia, Ghana, Mozambique, and South Africa [Real IPM], a regulatory moat that requires significant time and local trial data to replicate. Its flagship product, the Phytoseiulus predatory mite, is tailored to combat the red spider mite, a critical pest for the region's rose growers [Crunchbase]. This product-market fit is reinforced by a service layer of training, consultancy, and scouting, which locks in commercial growers who rely on consistent, residue-free yields for European export markets. This edge is durable as long as the company maintains its registration advantages and deepens its agronomic relationships, but it is perishable if a global competitor invests heavily in local R&D and field support to replicate the model.

The company's primary exposure lies in its potential dependency on its parent company's strategy and its limited scale outside of specific crop segments. As a member of the Biobest Group, Real IPM's autonomy for regional pricing, product development, and expansion could be constrained by corporate priorities. Furthermore, its stronghold in floriculture and high-value horticulture leaves it more vulnerable to sector-specific downturns and less diversified than competitors with broader row-crop or smallholder offerings. A named global competitor like Koppert could exploit this by launching a price-competitive, service-light biological product line targeted at the same growers, leveraging its brand and distribution to undercut on product cost alone.

The most plausible 18-month competitive scenario involves further consolidation of the biological inputs market in Africa. If regulatory standards for pesticide residues continue to tighten across Europe, the primary export market, the winner will be the entity that can most reliably guarantee compliance through a combination of effective products and verifiable grower protocols. In this scenario, Real IPM, backed by Biobest's resources, is well-positioned to win market share from smaller, product-only local producers and generic chemical suppliers. Conversely, if a major global agribusiness (e.g., Bayer or Syngenta) accelerates its own biocontrol portfolio in the region with significant promotional spending, the loser could be any regional player, including Real IPM, that cannot match the scale of marketing and channel incentives.

Data Accuracy: YELLOW -- Competitive positioning is inferred from the company's stated market focus and product claims [Real IPM, Crunchbase]. No direct competitor profiles were available in the cited sources for independent verification.

Opportunity

PUBLIC The prize for Real IPM, now operating within the Biobest Group, is establishing the biological control standard for high-value export agriculture across Sub-Saharan Africa, a position that could translate into a dominant regional franchise with recurring, high-margin revenue.

The headline opportunity is for Real IPM to become the de facto integrated pest management (IPM) partner for commercial horticulture and floriculture exporters across East Africa and beyond. This outcome is reachable because the company has already built the foundational assets: a registered product portfolio across seven African countries [Real IPM], a specialized focus on the residue-sensitive export market [Perplexity Sonar Pro Brief], and, critically, the operational scale and credibility that comes from being part of a global biological control leader [Biobest]. The acquisition by BioFirst Group (Biobest) in 2016 was not an endpoint but a strategic enabler, providing access to global R&D, supply chains, and a larger balance sheet to accelerate regional market capture [PitchBook]. The core bet is that as regulatory and consumer pressure against synthetic pesticides intensifies, the first-mover with localized production, training, and a broad product suite becomes the default solution.

Growth from this foundation could follow several distinct, high-conviction paths. The scenarios below outline how the company might scale beyond its current stronghold.

Scenario	What happens	Catalyst	Why it's plausible
Floriculture Standard-Bearer	Real IPM's predatory mite and biopesticide protocols become the mandated or preferred IPM system for the entire East African cut-flower export sector, a multi-billion dollar industry.	A major flower export association or a leading European retailer mandates verified biological control programs for all suppliers.	The company's primary product targets the red spider mite, the most damaging pest for rose growers [Crunchbase], and its products are already registered in key flower-exporting nations like Kenya, Ethiopia, and Uganda [Real IPM].
Smallholder Platform Expansion	The company successfully packages its bio-fertilizers and biopesticides into affordable, simple-to-use kits distributed through agro-dealer networks, reaching millions of small-scale farmers.	A strategic partnership with a major development finance institution or a regional agri-input distributor to fund and distribute the kits at scale.	The launch of Mazao Flourish, a bio-fertilizer aimed at promoting growth and reducing stress for a range of crops [Perplexity Sonar Pro Brief], indicates a product strategy moving beyond high-value export crops to broader agriculture.
Regional Manufacturing Hub	Real IPM's Kenyan facility evolves into Biobest's primary production and R&D center for the African continent, servicing new markets in West and Southern Africa.	Successful registration and commercial uptake of products in newer markets like Ghana and Mozambique creates a repeatable expansion blueprint.	The company already reports product registrations spanning from Ghana to Mozambique to South Africa [Real IPM], demonstrating a regulatory footprint that can be leveraged for deeper market penetration.

Compounding for Real IPM looks like a classic land-and-expand model fortified by biological expertise. An initial product sale, such as predatory mites for a flower farm, creates a recurring revenue stream and establishes trust. This trust is the entry point for expanding the service relationship into training, scouting, and consultancy [Perplexity Sonar Pro Brief]. Each new farm serviced generates field data on pest pressures and product efficacy, which informs localized R&D for new biopesticide strains or application methods,a data moat that generic importers cannot easily replicate. Furthermore, training a grower's staff creates a form of distribution lock-in, as farm technicians become proficient in Real IPM's specific protocols and product suite. The flywheel is already suggested by the company's service-offering expansion beyond mere product sales.

The size of the win can be framed by looking at the acquirer. Biobest Group, a global leader in biological pollination and pest control, is a privately held company with an estimated annual turnover exceeding €500 million (estimated). Real IPM's value within that group hinges on its ability to own the high-growth African biologicals segment. If the "Floriculture Standard-Bearer" scenario plays out, Real IPM could conceptually represent a regional business unit with revenues comparable to other successful agricultural input distributors in emerging markets, which often trade at revenue multiples of 2x-4x. A more concrete comparable is the entire biological crop protection market, which some analysts project to grow to over $10 billion globally by 2027 (estimated). Capturing a leading share in the high-value African export segment could position the Real IPM operation as a strategic asset worth several hundred million dollars within the broader Biobest portfolio (scenario, not a forecast).

Data Accuracy: YELLOW -- Opportunity scenarios are extrapolated from confirmed product registrations, market focus, and acquisition details; specific financial projections for the scenarios are not publicly available.

Sources

PUBLIC

1. [PitchBook] The Real IPM Company 2026 Profile: Valuation, Investors, Acquisition | https://pitchbook.com/profiles/company/162598-06

2. [Perplexity Sonar Pro Brief] Real IPM is a Kenya-based biological control / integrated pest management company founded in 2003 that makes biopesticides, predatory mites, bio-fertilizers, sticky traps, and seed-treatment products, and it also sells training, contract research, consultancy, and scouting services to growers. | https://realipm.com/

3. [Devex] Real IPM | Devex | https://www.devex.com/organizations/real-ipm-124640

4. [Real IPM] About Real IPM - Real IPM | https://realipm.com/about-us/

5. [Crunchbase] Real IPM - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/real-ipm

6. [MarketsandMarkets, 2022] Biopesticides Market by Type, Source, Mode of Application, Formulation, Crop Type and Region - Global Forecast to 2027 | https://www.marketsandmarkets.com/Market-Reports/biopesticides-267.html

7. [Biobest] Biobest acquires Real IPM - 2016-12-05 - Crunchbase Acquisition Profile | https://www.crunchbase.com/acquisition/biobest-acquires-real-ipm--fb5e7499